The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce costs. The agency approved a…
Nathaniel Weixel is a Health Reporter at The Hill. He covers a broad range of topics within health and wellness, including consumer health, public policy, and the intersection of healthcare with law and legal affairs, while also exploring issues related to cannabis and psychedelics. His work has been featured in numerous outlets, including MSN, FOX 2 Now, and WGN-TV.















